Idelalisib Recruiting Phase N/A Trials for Follicular Non-Hodgkin's Lymphoma Refractory

IndicationsStatusPurposePhase
RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03568929Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma